EMEA-002068-PIP01-16-M05 - paediatric investigation plan
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) [QIVc]
PIPHuman
Key facts
- Invented name
- Flucelvax Tetra
- Active Substance
- influenza vaccine (surface antigen, inactivated, prepared in cell cultures) [QIVc]
- Therapeutic area
- Infections and infestations
- Decision number
- P/0168/2024
- PIP number
- EMEA-002068-PIP01-16-M05
- Pharmaceutical form(s)
- Suspension for injection
- Condition(s) / indication(s)
- Prevention of influenza
- Route(s) of administration
- Intramuscular use
- Contact for public enquiries
Seqirus Netherlands B.V.
E-mail: seqirus.clinicaltrials@seqirus.com
Tel: +1 9088587365- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date